Autoimmune Hepatitis Patients Have Comparable Outcomes From Sars-Cov-2 Infection To Patients With Liver Disease Of Other Aetiology Despite Immunosuppression: International Registry Data

P50 Figure 1DiscussionThis is the largest reported cohort of patients with AIH and SARS-CoV-2 infection Major outcomes in AIH did not differ from those seen in other CLD patients despite widespread use of immunosuppression This will help guide treatment decisions and need for social distancing for AIH patients during the COVID-19 pandemic